Vaginal cancer: an iatrogenic disease?

International Journal of Health Services : Planning, Administration, Evaluation
K Weiss

Abstract

Presently we are witnessing two unique occurrences in the field of public health: the first demonstration of transplacental carcinogenesis in humans and the first drug-induced cancer epidemic in women under age 30. This article examines the current status of the vaginal cancer epidemic and possible reasons for the failure of governmental health agencies to recall and test the generation of females who were exposed to diethylstilbestrol (DES) in utero. Epidemiologic evidence indicates that the large majority of "DES daughters" may develop adenosis. The carcinogenicity of other estrogens in wide use is examined. It is pointed out that, although vaginal cancer in daughters exposed to DES in utero provided the clinical evidence to secure a Food and Drug Administration ban on DES as an additive to cattle feed, the FDA approved a new use of DES as a "morning-after pill" contraceptive even though the contraceptive contains 833,000 times the amount of DES banned for human consumption in beef. The lack of standards of informed consent in the testing of the morning-after pill on university women and the additional risk this presents to DES daughters are discussed. The sociopolitical and economic contributing factors to the vaginal cancer...Continue Reading

References

Mar 1, 1974·American Journal of Obstetrics and Gynecology·A L HerbstE Scully
Dec 1, 1973·Clinical Obstetrics and Gynecology·A L Herbst
Jul 1, 1974·American Journal of Obstetrics and Gynecology·P E Fehr, K A Prem
Jul 22, 1974·JAMA : the Journal of the American Medical Association·D H Mills
Apr 1, 1973·The British Journal of Venereal Diseases·V K Hopsu-Havu, C E Sonck
Feb 15, 1973·The New England Journal of Medicine·B E HendersonJ F Nolan
Nov 15, 1973·American Journal of Obstetrics and Gynecology·H Ulfelder
Jan 1, 1974·Obstetrics and Gynecology·A StaflW C Fetherston
Nov 2, 1972·The New England Journal of Medicine·J O AldrichD E Townsend
Sep 28, 1972·The New England Journal of Medicine·B S CutlerR E Scully
Sep 15, 1971·American Journal of Obstetrics and Gynecology·E H RuffoloJ C Fletcher
Oct 25, 1971·JAMA : the Journal of the American Medical Association·L K Kuchera
Dec 6, 1971·JAMA : the Journal of the American Medical Association·K S Huss
Apr 15, 1971·The New England Journal of Medicine·A L HerbstD C Poskanzer
Apr 15, 1971·The New England Journal of Medicine·A D Langmuir
Aug 12, 1971·The New England Journal of Medicine·P GreenwaldW S Burnett
Aug 12, 1971·The New England Journal of Medicine·J Folkman
Oct 15, 1968·American Journal of Obstetrics and Gynecology·A B Ng
Nov 13, 1967·JAMA : the Journal of the American Medical Association·H B TaylorH J Norris
Oct 25, 1971·JAMA : the Journal of the American Medical Association·L K Kuchera
Nov 1, 1953·American Journal of Obstetrics and Gynecology·W J DIECKMANNR E POTTINGER
Jan 16, 1954·Journal of the American Medical Association·O H PEARSONN E TREVES
May 1, 1954·American Journal of Obstetrics and Gynecology·E I JENSEN, E ØSTERGAARD
Jun 1, 1958·American Journal of Obstetrics and Gynecology·J W GOLDZIEHER, B B BENIGNO
Feb 1, 1959·American Journal of Obstetrics and Gynecology·A I SHERMAN, R B WOOLF
Apr 1, 1960·Acta Endocrinologica·J G FORSBERG
Jan 9, 1959·Annals of the New York Academy of Sciences·W U GARDNER
May 1, 1965·Cancer·W M CHRISTOPHERSONJ E PARKER
Apr 1, 1962·The Australian Journal of Experimental Biology and Medical Science·A G JABARA

❮ Previous
Next ❯

Citations

Jan 1, 1977·Health Education Monographs·N Milio
Nov 1, 1983·Issues in Health Care of Women·D L Zajac

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.